Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133340) titled 'Real-World Study of BCL2i in CLL' on Sept. 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: BCL2 Inhibitor Treatment Group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=344202
Published by HT Digital Content Services with permission from Health Daily Digest....